Synthesis, characterization, DFT analysis, molecular docking and anticancer investigations in colorectal carcinoma of a novel pyrazole-hydrazone zinc(II) complex.
1/5 보강
[UNLABELLED] The IMP ligand and its Zn(II) complex were characterized by different spectroscopic techniques, such as FT-IR, MS and NMR spectroscopy.
APA
Mermer A, Bayrak AM, et al. (2026). Synthesis, characterization, DFT analysis, molecular docking and anticancer investigations in colorectal carcinoma of a novel pyrazole-hydrazone zinc(II) complex.. Scientific reports, 16(1), 6391. https://doi.org/10.1038/s41598-026-35664-6
MLA
Mermer A, et al.. "Synthesis, characterization, DFT analysis, molecular docking and anticancer investigations in colorectal carcinoma of a novel pyrazole-hydrazone zinc(II) complex.." Scientific reports, vol. 16, no. 1, 2026, pp. 6391.
PMID
41698966 ↗
Abstract 한글 요약
[UNLABELLED] The IMP ligand and its Zn(II) complex were characterized by different spectroscopic techniques, such as FT-IR, MS and NMR spectroscopy. Density functional theory (DFT) calculations were used to elucidate their structural and electronic properties. The cytotoxic potential of both compounds was evaluated against the human colorectal carcinoma HCT116 cell line. The zinc(II) complex exhibited significantly enhanced antiproliferative activity compared to the free ligand, with an IC50 value of 24.56 μM after 48 h, while showing no cytotoxicity toward normal HEK293 cells. Colony formation and cell cycle analyses revealed that IMP-Zn significantly suppressed clonogenic growth and induced SubG0 phase accumulation, suggesting apoptosis-associated cell death. Molecular docking studies demonstrated stronger binding affinity of the zinc complex toward cancer-related molecular targets, supporting the experimental findings. Overall, these observations indicate that coordination of the pyrazole–hydrazone ligand to Zn(II) enhances its anticancer activity, highlighting IMP-Zn as a promising zinc-based metallotherapeutic candidate for colorectal cancer.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1038/s41598-026-35664-6.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1038/s41598-026-35664-6.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Virtual screening of novel alkaloids as potent inhibitors for G2032R-mutant ROS1 kinase in non-small-cell lung cancer.
- Novel Active Homo-Aza (Lactam) Steroidal Antimetabolites for the Treatment of Human Pancreatic and Colorectal Cancer.
- Decoding the Anti-Tumour Mechanism of ɑ-Solanine: SRC Inhibition and Ferroptosis Induction in Colon Cancer.
- Repurposing disulfiram for ALDH-positive NSCLC: Network-based inhibition of EGFR, COX-2, and MAPK1.
- Ursodeoxycholic Acid Alleviates DSS/AOM-Induced Colorectal Cancer in Mice by Inhibiting PI3K/Akt/mTOR Signaling Pathway.
- An Evaluation of the Interaction of Brefeldin A with Mitogen-Activated Protein Kinase 1 (MAPK1) and Protein Kinase C Alpha (PrKCα): Insights from Molecular Modelling Studies.